FDA.reportPublic FDA data

deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet

RxCUI
2701448
RxNorm name
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet
Display name
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet
Full name
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7e635909-c6fd-4f0d-ae77-cdff03653a20deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral TabletPSN8These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323
7e635909-c6fd-4f0d-ae77-cdff03653a20deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral TabletSCD8These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323
7e635909-c6fd-4f0d-ae77-cdff03653a20deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG (equivalent to vanzacaftor calcium dihydrate 4.24 MG) Oral TabletSY8These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323